生物技术-自然2013-09-05 2:58 AM

viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia : Nature Biotechnology : Nature Publishing Group

New high-dimensional, single-cell technologies offer unprecedented resolution in the analysis of heterogeneous tissues. However, because these technologies can measure dozens of parameters simultaneously in individual cells, data interpretation can be challenging. Here we present viSNE, a tool that allows one to map high-dimensional cytometry data onto two dimensions, yet conserve the high-dimensional structure of the data. viSNE plots individual cells in a visual similar to a scatter plot, while using all pairwise distances in high dimension to determine each cell's location in the plot. We integrated mass cytometry with viSNE to map healthy and cancerous bone marrow samples. Healthy bone marrow automatically maps into a consistent shape, whereas leukemia samples map into malformed shapes that are distinct from healthy bone marrow and from each other. We also use viSNE and mass cytometry to compare leukemia diagnosis and relapse samples, and to identify a rare leukemia population reminiscent of minimal residual disease. viSNE can be applied to any multi-dimensional single-cell technology.

KEYWORDS

SHARE & LIKE

COMMENTS

ABOUT THE AUTHOR

生物技术-自然

0 Following 0 Fans 0 Projects 12 Articles

SIMILAR ARTICLES

Reference genomes are required to understand the diverse roles of microorganisms in ecology, evolution, human and animal health, but most species remai

Read More

A low-error 16S ribosomal RNA amplicon sequencing method, in combination with whole-genome sequencing of >500 cultured isolates, was used to characteri

Read More

Delivery of short interfering RNAs (siRNAs) remains a key challenge in the development of RNA interference (RNAi) therapeutics. A better understanding

Read More

New high-dimensional, single-cell technologies offer unprecedented resolution in the analysis of heterogeneous tissues. However, because these technolo

Read More

In the version of this article initially published, there were two errors in the discussion of epigenetic marks on page 854. In sentence 4, paragraph 2

Read More

Genetic mutations causing human disease are conventionally thought to be inherited through the germ line from one’s parents and present in all somatic

Read More

Cell-based therapies for myelin disorders, such as multiple sclerosis and leukodystrophies, require technologies to generate functional oligodendrocyte

Read More

Transplantation of oligodendrocyte precursor cells (OPCs) is a promising potential therapeutic strategy for diseases affecting myelin. However, the der

Read More

It is currently not possible to predict which epitopes will be recognized by T cells in different individuals. This is a barrier to the thorough analys

Read More

Dysfunction of basal forebrain cholinergic neurons (BFCNs) and γ-aminobutyric acid (GABA) interneurons, derived from medial ganglionic eminence (MGE),

Read More